pharma
Biotest Farmaceutica Ltda
Biotest Pharma GmbH
Biotest Pharma is a pharma organization headquartered in Dreieich, DE. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and US
Dreieich, DE HQ
2 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dreieich, DE
- Employees
- 2
- Programs
- 1
- Drugs
- 5
- Patents
- 4
1001
Phase 3 · small molecule · Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)
1001 for Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19) is a Phase 3 program (small_molecule) at Biotest Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code 1001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Biotest Pharma GmbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)
- Status
- active
- Trials
- 1